Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change
1997528 citationsLara Schneider, Jason T. Olin et al.Alzheimer Disease & Associated Disordersprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Lara Schneider
Since
Specialization
Citations
This map shows the geographic impact of Lara Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Schneider more than expected).
This network shows the impact of papers produced by Lara Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Schneider. The network helps show where Lara Schneider may publish in the future.
Co-authorship network of co-authors of Lara Schneider
This figure shows the co-authorship network connecting the top 25 collaborators of Lara Schneider.
A scholar is included among the top collaborators of Lara Schneider based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Lara Schneider. Lara Schneider is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
6 of 6 papers shown
1.
Schneider, Lara, Richard Kennedy, Gary Cutter, & Nick C. Fox. (2010). Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam).1 indexed citations
Schneider, Lara, Jason T. Olin, Rachelle S. Doody, et al.. (1997). Validity and Reliability of the Alzheimerʼs Disease Cooperative Study-Clinical Global Impression of Change. Alzheimer Disease & Associated Disorders. 11. 22–32.528 indexed citations breakdown →
4.
Thal, L. J., Angelico Carta, Rachelle S. Doody, et al.. (1997). Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.. PubMed. 11 Suppl 3. 46–9.25 indexed citations
5.
Ferris, Steven H., Joan Mackell, Richard C. Mohs, et al.. (1997). A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.. PubMed. 11 Suppl 2. S1–12.39 indexed citations
6.
Schmitt, Frederick A., Wes Ashford, Christopher Ernesto, et al.. (1997). The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.. PubMed. 11 Suppl 2. S51–6.99 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.